Poll: Americans want price limits on drugs, devices and provider payments … Study subjects judge placebos with brand labels more effective than generics … Warren proposes bill to cover lack...
Senate panel digs into drug pricing
By
Nov 05, 2015
An investigation into pharmaceutical drug pricing has been launched following the widely-publicized, steep price increases of certain drugs, the Senate’s Special Committee on Aging announced Wednesday.
Hart promoted at GreenFields
Oct 30, 2015
GreenFields of Geneva has named Ron Hart as its director of building operations.
Resident, son dead in nursing home murder-suicide
By
Oct 27, 2015
An 85-year-old resident of a New Jersey facility and her 62-year-old son died Sunday in an apparent murder-suicide in the resident’s room, according to authorities.
Corless elected to AHCA board
Oct 13, 2015
Peter Corless, the EVP of Enterprise Development at OnShift, was elected as the Associate Business Member President for the American Health Care Association.
LTC Innovation Summit kicks off Tuesday
Oct 08, 2015
The second annual Louisville Innovation Summit takes place Tuesday and Wednesday with a gathering of 500 executives and entrepreneurs focusing on the future of aging care. More than 40 speakers and 15...
Profile: Sharon Colling
By
Elizabeth Newman
Oct 05, 2015
While many administrators enter long-term care because of a personal experience, American College of Health Care Administrators interim CEO Sharon Colling’s connection is different than most.
North America, Europe lead global nursing care market: analysis
Sep 22, 2015
High healthcare expenditures has put North America at the front of the global nursing care market, according to an analysis that projects into the next decade.
New drug rule could endanger $1.3 billion of Medicare funding
By
Sep 02, 2015
The pharmaceutical industry is pushing for a patent law change that could raise federal healthcare costs by $1.3 billion over the next decade.
Medicaid costs for antipsychotics to decrease as patents expire
By
Aug 26, 2015
Expiring patents for blockbuster antipsychotic medications is expected to increase use of the drugs’ generic versions and save Medicaid billions of dollars annually, a new study shows.